Article
Dexmedetomidine Regulates Macrophage Phenotype Remodeling Through AMPK/SIRT1 to Alleviate Inflammatory Mediators and Lung Injury.
Journal of biochemical and molecular toxicology - 1 Jan 2025
Zhao Yi-Si, Shi Ya-Kang, Li Ke-Feng, Ma Bei, Lin Shi-Hui, Xing Yu, Xu Fang
Abstract excerpt
Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is associated with high morbidity and mortality in the intensive care unit (ICU) and can cause excessive inflammation. Dexmedetomidine (DEX) is a drug that exerts anti-inflammatory effects. Identifying the anti-inflammatory mechanism of DEX in the context of ALI/ARDS possesses potential significance for the prevention and treatment of ARDS. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
